↓ Skip to main content

Nivolumab in metastatic urothelial carcinoma after platinum therapy (CheckMate 275): a multicentre, single-arm, phase 2 trial

Overview of attention for article published in Lancet Oncology, January 2017
Altmetric Badge
168

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (98th percentile)
  • High Attention Score compared to outputs of the same age and source (94th percentile)

Mentioned by

news
12 news outlets
blogs
1 blog
policy
4 policy sources
twitter
99 X users
patent
7 patents
facebook
1 Facebook page

Citations

dimensions_citation
1359 Dimensions

Readers on

mendeley
738 Mendeley